Much of the outrage targeting pharmaceutical companies over the past year has been focused on what many view to be the ugly side of free markets.
As a result, many consumer advocates have pushed for the government to impose greater restrictions on the drug industry to prevent rapacious actors such as Martin Shkreli from putting profit over people.
But a new report from Harvard claims that it's government policies that protect and accommodate pharmaceutical companies that has led to such high prices.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
